InsiderTrades

Form 4 for MET MetLife

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001099219-24-000053 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-29 2024-02-27 MET SCHOCK TAMARA EVP, CAO F - Tax $69.16 -4,251 21.4K -17% -$294.0K
DM 2024-02-29 2024-02-27 MET SCHOCK TAMARA EVP, CAO A - Grant — +10.1K 18.1K +127% —
D 2024-02-29 2024-02-27 MET SCHOCK TAMARA EVP, CAO A - Grant $0.00 +7,593 7,593 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-27 F D 4,251 $69.16 21,389 D — —
2 Common Common Stock 2024-02-27 A A 7,577 — 25,640 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation.
3 Common Common Stock 2024-02-27 A A 2,531 — 18,063 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Derivative Employee Stock Options (right to buy) 2024-02-27 A A 7,593 $0.00 7,593 D $69.16 · — to 2034-02-26 7,593 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.